The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(5-(3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl)pyridin-3-yl)-2-methoxy-5-morpholinopyridine-3-sulfonamide ID: ALA4870356
PubChem CID: 164623860
Max Phase: Preclinical
Molecular Formula: C26H30FN5O4S
Molecular Weight: 527.62
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1cncc(-c2ccc(CN3CCCC3)c(F)c2)c1
Standard InChI: InChI=1S/C26H30FN5O4S/c1-35-26-25(14-23(17-29-26)32-8-10-36-11-9-32)37(33,34)30-22-12-21(15-28-16-22)19-4-5-20(24(27)13-19)18-31-6-2-3-7-31/h4-5,12-17,30H,2-3,6-11,18H2,1H3
Standard InChI Key: KWXLBZZHWIABCM-UHFFFAOYSA-N
Molfile:
RDKit 2D
37 41 0 0 0 0 0 0 0 0999 V2000
17.8998 -16.3314 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.3125 -17.0413 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
18.7209 -16.3290 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.7289 -17.0323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0246 -17.4467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0300 -18.2615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7418 -18.6654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4461 -18.2510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4386 -17.4326 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.6049 -17.4504 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.7621 -21.1169 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.4664 -20.7025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4589 -19.8841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7493 -19.4838 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.0450 -19.8982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0503 -20.7130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7215 -16.2139 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.4258 -15.7995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8999 -16.2246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8999 -17.0418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1908 -17.4504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4818 -17.0418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4818 -16.2246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1908 -15.8160 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.7768 -17.4504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7768 -18.2676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0677 -18.6762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3586 -18.2676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3586 -17.4504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0677 -17.0418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6537 -18.6762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9446 -18.2676 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.8579 -17.4543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0572 -17.2848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6486 -17.9939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1968 -18.6015 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0677 -19.4934 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
4 9 2 0
2 10 1 0
5 2 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
11 16 1 0
7 14 1 0
17 18 1 0
4 17 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
19 24 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 30 1 0
25 30 2 0
31 32 1 0
28 31 1 0
22 25 1 0
10 20 1 0
32 33 1 0
33 34 1 0
34 35 1 0
35 36 1 0
36 32 1 0
27 37 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 527.62Molecular Weight (Monoisotopic): 527.2003AlogP: 3.52#Rotatable Bonds: 8Polar Surface Area: 96.89Molecular Species: NEUTRALHBA: 8HBD: 1#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 7.07CX Basic pKa: 8.45CX LogP: 1.43CX LogD: 1.28Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.48Np Likeness Score: -1.97
References 1. Down K, Amour A, Anderson NA, Barton N, Campos S, Cannons EP, Clissold C, Convery MA, Coward JJ, Doyle K, Duempelfeld B, Edwards CD, Goldsmith MD, Krause J, Mallett DN, McGonagle GA, Patel VK, Rowedder J, Rowland P, Sharpe A, Sriskantharajah S, Thomas DA, Thomson DW, Uddin S, Hamblin JN, Hessel EM.. (2021) Discovery of GSK251: A Highly Potent, Highly Selective, Orally Bioavailable Inhibitor of PI3Kδ with a Novel Binding Mode., 64 (18.0): [PMID:34510892 ] [10.1021/acs.jmedchem.1c01102 ]